BTAI
#4888
BioXcel Therapeutics, Inc. - Common Stock
0.1 9 USD
-0.74%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-73.61%
Variación mensual
-77.38%
Variación en los últimos 6 meses
-88.48%
Cambio anual
-87.97%
Cierres anteriores
0.7 2
Open
0.1 7
Mínimo
0.1 7
Máximo
0.2 0
Volumen
1 689
Financials
- Market Capitalization 5.95 M
- Employee 29
- Founded 2017
- CEO N/A
- Website www.bioxceltherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00K20GVD2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.28
Relación precio/flujo de caja
30.42
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4884 |  LIMN Liminatus Pharma, Inc. - Class A Common Stock | 4.49 USD | +2.05% | -17.01% | +3981.82% | +66.30% | 6.03 M USD | ||
| 4885 |  XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 2.54 USD | -1.55% | -4.51% | -5.93% | +182.85% | 6.01 M USD | ||
| 4891 |  BGMS Bio Green Med Solution, Inc. - Common Stock | 0.89 USD | 0.00% | +1.14% | 0.00% | -85.17% | 5.89 M USD | ||
| 4899 |  PCSA Processa Pharmaceuticals, Inc. - Common Stock | 2.07 USD | -2.82% | -1.43% | +13.11% | -6.96% | 5.78 M USD |